List of companies in Redmile Group's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Mammoth Biosciences is an American company based in San Francisco founded on June 1, 2017. Mammoth Biosciences uses CRISPR technology to develop bio-sensing technologies for diagnostics in industries such as healthcare, agriculture, manufacturing, and forensics and genome editing therapeutics. | ||||||
Augmedix is a technology-enabled service platform that simplifies how physicians work and deal with patients and medical documentation, with physician-wearable technology. | ||||||
Cabaletta Bio is a biotechnology company developing cellular therapies for autoimmune disease. | ||||||
A biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation | ||||||
A synthetic biology company using CRISPR to develop a portfolio of genetic medicines. | ||||||
BioNTech is a German company that develops immunotherapies for the treatment of cancer and other diseases. | ||||||
An exosome therapeutics company founded in 2016 and based in Oxford, UK, that uses exosomes to deliver small and large molecule therapeutics. The company has a proprietary technology to modify exosomes to target specific organs such as the brain and central nervous system. | ||||||
Wave Life Sciences is a biotechnology company developing therapies to treat genetic diseases. | ||||||
AlloVir (formerly ViraCyte) is a company that develops cell therapies for patients suffering from life-threatening virus-associated diseases. | ||||||
Foundation Medicine is a Cambridge, Massachusetts-based pharmaceutical company developing diagnostic and treatment solutions for cancer care founded in 2010 by Alexis Borisy. | ||||||
Adagio Therapeutics is a Waltham, Massachusetts-based biotechnology company involved in the research and development of therapeutic pharmaceuticals. | ||||||
Genalyte is an American medical analytics and diagnostics company. | ||||||
A biotechnology company specializing in creating therapeutics for neurological disorders. It was founded in 2014 and is located in New York City. | ||||||
Gritstone Oncology is a Emeryville, California-based biotechnology company developing neoantigen-specific cancer immunotherapies. | ||||||
Blueprint Medicines is a biotechnology company that is working to improve human health. | ||||||
Verve Therapeutics is a company in Cambridge, Massachusetts. | ||||||
IGM Biosciences is an antibody Treatments. | ||||||
Kymera Therapeutics is a Cambridge, Massachusetts-based biotechnology company specialized in the field of targeted protein degradation. | ||||||
Atreca is a biotechnology company founded in 2011 by Jonathan Woo, Guy Cavet, Tito A Serafini, Daniel Emerling, Paulette Dillon, Wayne Volkmuth and Yann Chong Tan. | ||||||
TCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies. | ||||||
A company focused on mapping and controlling the genes to treat diseases | ||||||
AbSci is an e. Coli expression system for protein production founded in 2011 by Sean McClain. | ||||||
Stoke Therapeutics is a biopharma company that develops RNA-targeted treatments for severe genetic diseases. | ||||||
A genetic information company and genetic testing services provider. | ||||||
Akero Therapeutics is a Cambridge, Massachusetts-based biotechnology company focused on reversing the NASH epidemic by restoring the body's metabolism to a balanced state. |
